[e-farmacos] Drug Safety Update: Volume 1, Issue 5, December 2007

["Canas, Martin" <macanas@netverk.com.ar>]

Estimadas y estimados,

Esta disponible el

Drug Safety Update: Volume 1, Issue 5, December 2007

con el siguiente  contenido

Drug safety advice

Recombinant human erythropoietins: new prescribing advice

Rosiglitazone and pioglitazone: cardiovascular safety

Dosulepin: measures to reduce risk of fatal overdose

ACE inhibitors and angiotensin II receptor antagonists: not for use in
pregnancy

Short-acting? agonists: myocardial ischaemia

Yellow Card scheme update electronic reporting

Hot topics
Varenicline: possible effects on driving, and psychiatric illness
NSAIDs and coxibs: balancing of cardiovascular and gastrointestinal risks

Stop Press
Aprotinin: suspension of Marketing Authorisations
Lumiracoxib: suspension of Marketing Authorisations
Strontium ranelate: risk of severe allergic reactions
Talc for pleurodesis: risk of adverse events
Recent letters to healthcare professionals
Other information from the MHRA
New sections on the MHRA website

disponible en:
http://www.mhra.gov.uk/home/idcplgIdcService=GET_FILE&dDocName=CON2033217&R
evisionSelectionMethod=LatestReleased

Saludos,

Martin

Martin Canas
GAPURMED
La Plata
(Argentina)
macanas@netverk.com.ar